The global head and neck cancer therapeutics market is experiencing significant growth, projected to expand from USD 2.0 billion in 2025 to USD 6.2 billion by 2035, with a compound annual growth rate (CAGR) of 12.1% Future Market Insights . This surge is driven by increasing incidences of HPV-related cancers, tobacco and alcohol consumption, and advancements in treatment modalities... https://www.expertmarketresearch.com/reports/head-and-neck-cancer-therapeutics-market